Article
Inhibition of HECT E3 ligases as potential therapy for COVID-19
24 Mar 2021
Abstract excerpt
SARS-CoV-2 is responsible for the ongoing world-wide pandemic which has already taken more than two million lives. Effective treatments are urgently needed. The enzymatic activity of the HECT-E3 ligase family members has been implicated in the cell egression phase of deadly RNA viruses such as Ebola through direct interaction of its VP40 Protein. Here we report that HECT-E3 ligase family members such as NEDD4 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
